Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

pGWAS-Portal: a comprehensive online platform for integrative post-genome-wide association study analysis.

BMC genomics·2026
Same author

Integrative Transcriptomics and Machine Learning Identify Macrophage-Associated Biomarkers in Hypertrophic Cardiomyopathy.

International journal of molecular sciences·2026
Same author

Genome-Wide Cross-Trait Analysis Dissects the Shared Genetic Architecture Between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Human mutation·2026
Same author

DECODE: deep learning-based common deconvolution framework for various omics data.

Nature methods·2026
Same author

Molecularly defined renal cell carcinomas: practical approaches for surgical pathologists.

Histopathology·2025
Same author

gutMSNP: a comprehensive database for human gut microbial single-nucleotide polymorphisms.

Nucleic acids research·2025
Same journal

Correction to "Mathematical Modelling of COVID-19 Transmission in Kenya: A Model with Reinfection Transmission Mechanism".

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Empirical Analysis of the Nursing Effect of Intelligent Medical Internet of Things in Postoperative Osteoarthritis.

Computational and mathematical methods in medicine·2025
Same journal

RETRACTION: Evaluation and Analysis of the Intervention Effect of Systematic Parent Training Based on Computational Intelligence on Child Autism.

Computational and mathematical methods in medicine·2024
Same journal

RETRACTION: Humanistic Spirit Training of Medical Students Based on Multisource Medical Data Fusion.

Computational and mathematical methods in medicine·2024
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

323

Identification of Nine mRNA Signatures for Sepsis Using Random Forest.

Jing Zhou1,2, Siqing Dong3, Ping Wang4

  • 1Intensive Care Unit, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.

Computational and Mathematical Methods in Medicine
|March 29, 2022
PubMed
Summary
This summary is machine-generated.

Identifying a nine-mRNA signature could significantly improve early sepsis diagnosis. This molecular biomarker panel aids in distinguishing infected patients, potentially increasing survival rates and guiding treatment decisions for sepsis.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

932
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Related Experiment Videos

Last Updated: Sep 28, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

323
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

932
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genomics

Background:

  • Sepsis presents a high mortality rate, underscoring the urgent need for improved diagnostic tools.
  • Current diagnostic methods lack reliable molecular biomarkers for early and accurate sepsis detection.
  • Effective sepsis treatment is hindered by the absence of specific indicators to differentiate infected from uninfected individuals.

Purpose of the Study:

  • To identify a novel mRNA signature for early sepsis diagnosis.
  • To discover reliable molecular biomarkers for distinguishing sepsis patients from healthy controls.
  • To analyze the functional roles of differentially expressed genes in sepsis.

Main Methods:

  • Downloaded and analyzed gene expression datasets (GSE154918, GSE131761) from the GEO database.
  • Identified differentially expressed genes (DEGs) using the Limma package.
  • Employed a random forest model to identify a predictive mRNA signature for sepsis.

Main Results:

  • Identified 384 common DEGs across sepsis contrast groups, with increased gene dysregulation correlating with disease severity.
  • A panel of 279 key DEGs was selected, enriched for functions related to neutrophil activity and immune response.
  • A nine-mRNA signature (MCEMP1, PSTPIP2, CD177, GCA, NDUFAF1, CLIC1, UFD1, SEPT9, UBE2A) demonstrated high diagnostic accuracy (AUC) via cross-validation.

Conclusions:

  • The identified nine-mRNA signature serves as a promising biomarker for distinguishing sepsis from healthy states.
  • This molecular signature has the potential to facilitate early sepsis diagnosis and improve patient outcomes.
  • Further validation of this mRNA panel could lead to advancements in clinical sepsis management.